GC-MS and GC-MS/MS measurement of the cardiovascular risk factor homoarginine in biological samples

Arslan Arinc Kayacelebi1, Bibiana Beckmann, Frank-Mathias Gutzki

  • 1Institute of Clinical Pharmacology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625, Hannover, Germany.

Amino Acids
|June 14, 2014
PubMed

Insights

L-Homoarginine (hArg) is a cardiovascular risk factor. New GC-MS and GC-MS/MS methods accurately quantify hArg in human plasma, urine, and sputum, aiding its study in health and disease.

Area of Science:

  • Biochemistry
  • Analytical Chemistry
  • Clinical Chemistry

Background:

  • L-Homoarginine (hArg) is recognized as a novel cardiovascular risk factor.
  • Elevated hArg levels are associated with a poor prognosis in heart failure patients.
  • Accurate quantification methods are needed to study hArg's role in human physiology and pathology.

Purpose of the Study:

  • To develop and validate robust gas chromatography-mass spectrometry (GC-MS) and GC-MS/MS methods.
  • To enable the quantitative determination of hArg in diverse biological samples.
  • To assess hArg concentrations in human plasma, urine, and sputum.

Main Methods:

  • Development of GC-MS and GC-MS/MS assays for hArg quantification.
  • Use of derivatization with methyl ester tri(N-pentafluoropropionyl).
  • Employing deuterated hArg or labeled arginine as internal standards and electron-capture negative-ion chemical ionization.

Main Results:

  • Validated GC-MS and GC-MS/MS methods provide accurate and precise hArg quantification.
  • Similar hArg concentrations were obtained using both GC-MS and GC-MS/MS.
  • Plasma and serum hArg levels were comparable, indicating minimal preanalytical variation.
  • Creatinine-corrected urinary hArg excretion in healthy subjects showed considerable variability.
  • A positive correlation was observed between urinary hArg and ADMA levels.

Conclusions:

  • GC-MS is a suitable method for accurate hArg quantification in biological samples.
  • The developed methods are valuable tools for investigating hArg's physiological and pathological roles.
  • hArg is present at approximately 2 µM in human plasma and may be a component of plasma proteins.